Improved methods and standards for telomerase detection: Quantitative histopathology using antibody staining Improved telomerase detection methods

Biotechnic and Histochemistry

Volumn 84, Issue 5, 2009, Pages 195-206

  Jakupciak, J P ^a,b   Gallant, N D ^a,c   Smith, A H ^a   Becker, M L ^a   Tona, A ^a   Atha, D H ^a  

^a NATIONAL INSTITUTE OF STANDARDS AND TECHNOLOGY   (United States)

^b Cosmosid Inc ^*  (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Automation; Biomarker; Cancer; Flow cytometry; Fluorescence microscopy; Immunohistochemistry; Molecular imaging; Quantitation; Telomerase assay

Indexed keywords

ENZYME ANTIBODY; TELOMERASE;

ARTICLE; CELL LINE; CONTROLLED STUDY; CRYSTAL STRUCTURE; ENZYME ASSAY; FIBROBLAST; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOHISTOCHEMISTRY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STANDARD; TUMOR CELL; TUMOR CELL CULTURE; VALIDATION STUDY;

ANTIBODIES; FLUORESCENT DYES; HUMANS; IMMUNOHISTOCHEMISTRY; METHODS; MICROSCOPY, FLUORESCENCE; REFERENCE STANDARDS; TELOMERASE; TUMOR CELLS, CULTURED;

EID: 70449428710     PISSN: 10520295     EISSN: 14737760     Source Type: Journal    
DOI: 10.1080/10520290903039060     Document Type: Article

References (29)

1. Apple SK (2006) Variability in gross and microscopic pathology reporting in excisional biopsies of breast cancer tissue. Breast J. 12: 145-149.
2. Atha DH, Miller K, Sanow AD, Xu J, Hess JL, Wu OC, Wang W, Srivastava S, Highsmith WE (2003) Highthroughput analysis of telomerase by capillary electrophoresis. Electrophoresis 24: 109-114.
3. Blackburn EH (1991) Structure and function of telomeres. Nature 350: 569-572.
4. Colgin LM, Wilkinson C, Englezou A, Kilian A, Robinson MO, Reddel RR (2000) The hTERT a splice variant is a dominant negative inhibitor of telomerase activity. Neoplasia 2: 426-432.
5. Collan Y (1984) Morphometry in pathology: another look at diagnostic histopathology. Pathol. Res. Pract. 179: 189-192.
6. Elkak AE, Meligonis G, Salhab M, Mitchell B, Blake JRS, Newbold RF, Mokbel K (2005) hTERT protein expression is independent of clinicopathological parameters and cMyc protein expression in human breast cancer. J. Carcinogen 4: 17-25.
7. Emrich T, Chang SY, Karl G, Panzinger B, Santini C (2002) Quantitative detection of telomerase components by real-time on-line PCR analysis with the LightCycler. Methods Mol. Biol. 191: 99-108.
8. Gallant ND, Michael KE, Garcia AJ (2005) Cell adhesion strengthening: contributions of adhesive area, integrin binding and focal adhesion assembly. Mol. Biol. Cell 16: 4329-4340.
9. Gil J, Wu HS (2003) Applications of image analysis to anatomic pathology: realities and promises. Cancer Invest. 21: 950-959.
10. Hess JL, Atha DH, Xu J, Highsmith WE (2004) Telomerase activity measurement in magnetically captured epithelial cells: comparison of slab-gel and capillary electrophoresis. Electrophoresis 25: 1852-1859.
11. Jakupciak JP, Barker PE, Wang W, Srivastava S, Atha DH (2005) Standards for telomerase assays: TRAP/PCR, Real-time TRAP/PCR, and hTERTmRNA/RT-PCR. Clin. Chem. 51: 1443-1450.
12. Jakupciak JP, Wang W, Barker PE, Srivastava S, Atha DH (2004) Analytical validation of telomerase activity for cancer early detection. J. Mol. Diagn. 6: 157-165.
13. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW (1994) Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011-2015.
14. Levy MZ, Allsopp RC, Futcher AB, Greider CW, Harley CB (1992) Telomere end-replication problem and cell aging. J. Mol. Biol. 225: 951-960.
15. Maruvada P, Wang W, Wagner PD, Srivastava S (2005) Biomarkers in molecular medicine: cancer detection and diagnosis. Biotechniques April (Suppl.): 9-15.
16. McGruder BM, Atha DH, Wang W, Huppi K, Wei WQ, Abnet CC, Qiao YL, Dawsey SM, Taylor PR, Jakupciak JP (2006) Real-time telomerase assay of less-invasively collected esophageal cell samples. Cancer Lett. 244: 91-100.
17. O'Connell CD, Atha DH, Jakupciak JP (2005) Standards for validation of cancer biomarkers. Cancer Biomarkers 1: 233-239.
18. Obyashiki JH, Ohyashiki K, Toyama K, Shay JW (1996) A nonradioactive, fluorescence-based telomeric repeat amplification protocol to detect and quantitate telomerase activity. TIG 12: 395-396.
19. Piatyszek MA, Kim NW, Weinrich SL, Hiyama K, Hiyama E, Wright WE, Shay JW (1995) Detection of telomerase activity in human cells and tumors by a telomeric repeat amplification protocol. Methods Cell Sci. 17: 1-15.
20. Shay JW (1999) Telomerase and cancer In: Molecular Pathology of Early Cancer Srivastava S, Hensen DE, Gazdar A, Eds. IOS Press, Washington, DC. pp. 405-424.
21. Sokal RR, Rohlf FJ (1995) Biometry: the Principles and Practice of Statistics in Biological Research. 3rd ed W.H. Freeman, New York. pp. 409-419.
22. Taylor CR (2000) The total test approach to standardization of immunohistochemistry. Arch. Pathol. Lab. Med. 124: 945-951.
23. Tosi P, Cottier H (1989) What's new in quantitative pathology? Past developments and outlook. Pathol. Res. Pract. 184: 652-655.
24. Wang SL, Wu MT, Yang SF, Chan HM, Chai CY (2005) Computerized nuclear morphometry in thyroid follicular neoplasms. Pathol. Int. 55: 703-706.
25. Wu Y-L, Dudognon C, Nguyen E, Hillion J, Pendino F, Tarkanyi I, Aradi J, Lanotte M, Tong J-H, Chen G-Q, Segal-Bendirdjian S (2006) Immunodetection of human telomerase reverse-transcriptase (hTERT) reappraised: nucleolin and telomerase cross paths. J. Cell Sci. 119: 2797-2806.
26. Xiao Y (2006) Antibodies to human telomerase reverse transcriptase. SAIC Patent application filed June 26, 2006, attorney docket number 000479.00163.
27. Xiao Y, Gao X, Gannot G, Emmert-Buck MR, Srivastava S, Wagner PD, Amos MD, Barker PE (2008) Quantitation of HER2 and telomerase biomarkers in solid tumors with IgY antibodies and nanocrystal detection. Int. J. Cancer. 122: 2178-2186.
28. Yi X, Shay JW, Wright WE (2001) Quantitation of telomerase components and hTERT mRNA splicing patterns in immortal human cells. Nucl. Acids Res. 29: 4818-4825.
29. Yi X, White DM, Aisner DL, Baur JA, Wright WE, Shay JW (2000) An alternate splicing variant of the telomerase catalytic subunit inhibits telomerase activity. Neoplasia 2: 433-440